Dr Marthak has vast experience in Phase I
clinical research working for Novartis for
13 years pioneering phase I studies in India
as early as 1978-79. Dr Marthak has also
initiated clinical trials for USFDA
submission and data management while working
with Pfizer as Vice President Clinical
Research. More recently Dr Marthak has
worked with Ranbaxy as Vice President
Clinical Research and with German Remedies
as Medical Director
Dr Marthak is an accomplished speaker having
delivered lectures on clinical research in
various National and International Forums
including being invited by Harvard business
school to deliver a lecture on Scope of
Clinical Research in India and by Stanley
business school to talk on CROs and Clinical
Research in India. He is President -
Association of Medical Advisors of
Pharmaceutical Industry and an Executive
Committee Member – International Federation
of Association of Pharmaceutical Physicians
as well as being a Board Member for
designing the modules for Academy of
Clinical Research, Chief organizer of the
International conference of Clinical
Research held by CII-New Delhi in the year
2002 and a member of the Faculty for
Pharmaceutical medicine – University of
London, Fellow member - American college of
Chest Physician, and Fellow member - Royal
Society of Medicine.
Dr Marthak is actively involved with
regulatory authorities like US FDA, UK MHRA,
China SFDA, South Africa MCC, MHCW and India
–DCGI He is a Member of the Medical
Committee- Indian Drug Manufacturer’s
Association, a Member-India Task Force- DIA,
USA, a Founder Member- Clinical Research
Institute, India and a Member of the
Delegation- Gujarat Government, Vibrant
Gujarat.
Among his most recent achievements for Veeda
Clinical Research Dr Marthak has been
responsible for setting up a Renal Phase-I
unit at Nadiad, India |
